John Bradley
Overview
Explore the profile of John Bradley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
246
Citations
7046
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mmbando A, Ngonzi A, Mshamu S, Bradley J, Bojstrup T, Ngowo H, et al.
Parasit Vectors
. 2025 Mar;
18(1):106.
PMID: 40082998
Background: Diarrhoeal disease is the third leading cause of death in children under 5 years old with domestic flies acting as important mechanical vectors of diarrhoeal pathogens. To assess the...
2.
Stewart A, Zachman D, Castellano-Escuder P, Kelly L, Zolyomi B, Aiduk M, et al.
bioRxiv
. 2025 Mar;
PMID: 40060603
Understanding how cellular pathways interact is crucial for treating complex diseases like cancer, yet our ability to map these connections systematically remains limited. Individual gene-gene interaction studies have provided insights...
3.
Fireizen Y, Ahmed M, Vigers T, Akong K, Ryu J, Hahn A, et al.
Pediatr Pulmonol
. 2025 Feb;
60(3):e71019.
PMID: 40018992
Rationale: The introduction of elexacaftor/tezacaftor/ivacaftor (ETI), a highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy, to younger ages and the COVID-19 pandemic have significantly reduced pulmonary exacerbations requiring...
4.
Kamelian K, Sievers B, Chen-Xu M, Turner S, Cheng M, Altaf M, et al.
Sci Adv
. 2025 Feb;
11(7):eadq3342.
PMID: 39937891
Immune suppression poses a challenge to vaccine immunogenicity. We show that serum antibody neutralization against SARS-CoV-2 Omicron descendants was largely absent post-doses 1 and 2 in individuals with vasculitis treated...
5.
Lissenden N, Bradley J, Menze B, Wondji C, Edi C, Koudou B, et al.
Malar J
. 2025 Feb;
24(1):34.
PMID: 39905437
Background: Restricting the placement of active ingredients (AIs) to specific panels on insecticide-treated nets (ITNs) has the potential to reduce the amount of AI required to treat a net. If...
6.
Kanyama C, Kouanfack C, Nyirenda S, Mfinanga S, Kivuyo S, Beaumont E, et al.
Lancet Glob Health
. 2025 Jan;
13(2):e345-e354.
PMID: 39890234
Background: CNS infections cause approximately a third of HIV-related deaths. The Driving Reduced AIDS-Associated Meningo-encephalitis Mortality DREAMM study aimed to prospectively diagnose the aetiology of HIV-related CNS infection in five...
7.
Datoo M, Hill A, Beaumont E, Bradley J
Lancet
. 2025 Jan;
405(10475):299-301.
PMID: 39863365
No abstract available.
8.
Wolfgang A, McClair V, Schnurr P, Holtzheimer P, Woolley J, Stauffer C, et al.
Am J Psychiatry
. 2025 Jan;
182(1):17-20.
PMID: 39741441
No abstract available.
9.
Natama H, Salkeld J, Some A, Soremekun S, Diallo S, Traore O, et al.
Lancet Infect Dis
. 2024 Dec;
PMID: 39672183
Background: Two pre-erythrocytic vaccines (R21/Matrix-M and RTS,S/AS01) are now approved for Plasmodium falciparum malaria. However, neither induces blood-stage immunity against parasites that break through from the liver. RH5.1/Matrix-M, a blood-stage...
10.
Hutchins H, Pretorius E, Bradley J, Teixeira da Silva E, Vasileva H, Ndiath M, et al.
Lancet Infect Dis
. 2024 Nov;
PMID: 39551062
Background: Arthropod vectors feeding on the blood of individuals treated with ivermectin have substantially increased mortality. Whether this effect will translate into a useful tool for reducing malaria burden at...